Organic compounds
1234 Compounds of formula I in free or salt form, wherein R, R, R, Rand X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Budd, Emma Hatto, Julia Doris Ida Hayler, Judy Fox Legrand, Darren Mark Valade, Barbara |
| description | 1234 Compounds of formula I in free or salt form, wherein R, R, R, Rand X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07754746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07754746</sourcerecordid><originalsourceid>FETCH-uspatents_grants_077547463</originalsourceid><addsrcrecordid>eNrjZBD0L0pPzMtMVkjOzy3IL81LKeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwNzc1MTcxMyYCCUAydggsQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Organic compounds</title><source>USPTO Issued Patents</source><creator>Budd, Emma ; Hatto, Julia Doris Ida ; Hayler, Judy Fox ; Legrand, Darren Mark ; Valade, Barbara</creator><creatorcontrib>Budd, Emma ; Hatto, Julia Doris Ida ; Hayler, Judy Fox ; Legrand, Darren Mark ; Valade, Barbara ; Novartis AG</creatorcontrib><description>1234 Compounds of formula I in free or salt form, wherein R, R, R, Rand X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7754746$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7754746$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Budd, Emma</creatorcontrib><creatorcontrib>Hatto, Julia Doris Ida</creatorcontrib><creatorcontrib>Hayler, Judy Fox</creatorcontrib><creatorcontrib>Legrand, Darren Mark</creatorcontrib><creatorcontrib>Valade, Barbara</creatorcontrib><creatorcontrib>Novartis AG</creatorcontrib><title>Organic compounds</title><description>1234 Compounds of formula I in free or salt form, wherein R, R, R, Rand X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZBD0L0pPzMtMVkjOzy3IL81LKeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwNzc1MTcxMyYCCUAydggsQ</recordid><startdate>20100713</startdate><enddate>20100713</enddate><creator>Budd, Emma</creator><creator>Hatto, Julia Doris Ida</creator><creator>Hayler, Judy Fox</creator><creator>Legrand, Darren Mark</creator><creator>Valade, Barbara</creator><scope>EFH</scope></search><sort><creationdate>20100713</creationdate><title>Organic compounds</title><author>Budd, Emma ; Hatto, Julia Doris Ida ; Hayler, Judy Fox ; Legrand, Darren Mark ; Valade, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_077547463</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Budd, Emma</creatorcontrib><creatorcontrib>Hatto, Julia Doris Ida</creatorcontrib><creatorcontrib>Hayler, Judy Fox</creatorcontrib><creatorcontrib>Legrand, Darren Mark</creatorcontrib><creatorcontrib>Valade, Barbara</creatorcontrib><creatorcontrib>Novartis AG</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Budd, Emma</au><au>Hatto, Julia Doris Ida</au><au>Hayler, Judy Fox</au><au>Legrand, Darren Mark</au><au>Valade, Barbara</au><aucorp>Novartis AG</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Organic compounds</title><date>2010-07-13</date><risdate>2010</risdate><abstract>1234 Compounds of formula I in free or salt form, wherein R, R, R, Rand X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07754746 |
| source | USPTO Issued Patents |
| title | Organic compounds |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T07%3A59%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Budd,%20Emma&rft.aucorp=Novartis%20AG&rft.date=2010-07-13&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07754746%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |